Cover Image

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne

Abstract is missing (Short communication)

Saved in:

Bibliographic Details
Main Authors:	Fabienne Ballanger (Author), Nicole Auffret (Author), Marie-Thérèse Leccia (Author), Jean Paul Claudel (Author), Brigitte Dréno (Author)
Format:	Book
Published:	Medical Journals Sweden, 2023-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Truncal Acne in Adolescents and Young Adults: Self-reported Perception
by: Fabienne Ballanger, et al.
Published: (2023)

A case series of acne following Janus kinase inhibitors in patients with atopic dermatitis
by: Sang-Doo Lee, MD, et al.
Published: (2022)

Itch and Janus Kinase Inhibitors
by: Yujin Han, et al.
Published: (2023)

Acne keloidalis nuchae in a patient with atopic dermatitis treated with Janus kinase inhibitor upadacitinib
by: Nicolas Caudrelier, MD, et al.
Published: (2023)

Janus kinase inhibitors: jackpot or potluck?
by: Pavithran Keechilat, et al.
Published: (2012)

Janus kinase inhibitors and adverse events of acne in dermatologic indications: a systematic review and network meta-analysis
by: Bai-lin Chen, et al.
Published: (2024)

Janus Kinase inhibitors in dermatology: a review
by: Bárbara Vieira-Granja, et al.
Published: (2023)

Janus Associated Kinases Inhibitors in the Pharmacological Thera
by: Daniela Santos1, et al.
Published: (2017)

Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
by: Vishal R. Tandon, et al.
Published: (2022)

Successful Treatment of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome with Baricitinib, a Janus Kinase Inhibitor
by: Yang J, et al.
Published: (2024)

Bullous pemphigoid treated with Janus kinase inhibitor upadacitinib
by: David Nash, BHSc, et al.
Published: (2023)

Role of janus kinase inhibitors in the treatment of alopecia areata
by: Triyangkulsri K, et al.
Published: (2018)

Janus kinase inhibitors - their current applications and future prospects
by: Natalia Wierzbowska, et al.
Published: (2022)

Janus kinase inhibitors: between prescription authorization and reimbursability
by: F.R. Spinelli, et al.
Published: (2023)

The Upadacitinib - New Janus Kinase Inhibitor - Literature Review
by: Michalina Grzelka, et al.
Published: (2024)

Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor
by: Singer J, et al.
Published: (2016)

Basics of Janus kinases: a review
by: Hanan R Nada, et al.
Published: (2020)

EMERGING USE OF JANUS KINASE INHIBITORS FOR ORAL LICHEN PLANUS
by: Mihaela Paula Toader, et al.
Published: (2024)

Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders
by: Robert Roskoski, Jr
Published: (2022)

The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current Insights
by: Eric Toussirot
Published: (2022)

Janus kinases: dermatological perspective, a review
by: Hanan R Nada, et al.
Published: (2020)

Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor
by: Carine M. Lama, MS, et al.
Published: (2023)

Association of myalgias with compounded topical Janus kinase inhibitor use in vitiligo
by: Shanthi Narla, MD, et al.
Published: (2020)

Janus Kinase Inhibitors as Successful Treatment Alternative in Dupilumab-Induced Psoriasis
by: Lina Weiss, et al.
Published: (2024)

Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease
by: Huo R, et al.
Published: (2022)

A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
by: Yoshiya Tanaka
Published: (2023)

Potential Use of Janus Kinase Inhibitors in the Treatment of Systemic Lupus Erythematosus
by: Huo R, et al.
Published: (2023)

Acne and Acneiform Eruptions
Published: (2017)

The role of janus kinases in the treatment of autoimmune skin diseases
by: Arnold Kukowka, et al.
Published: (2021)

Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient
by: Sineida Berbert Ferreira, et al.
Published: (2021)

Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib
by: Miguel Nogueira, et al.
Published: (2021)

Antipruritic Effects of Janus Kinase Inhibitor Tofacitinib in a Mouse Model of Psoriasis
by: Takashi Hashimoto, et al.
Published: (2019)

Disparities in Janus kinase inhibitor access for alopecia areata: a retrospective analysis
by: Elizabeth J. Klein, MD, et al.
Published: (2024)

Janus-kinase Inhibitors in Pathogenesis and Management of Chronic Urticaria: A Review of the Literature
by: Sepideh Darougar, et al.
Published: (2023)

The FDA has expanded the indications for the appointment of an oral janus kinase 1 inhibitor
by: article Editorial
Published: (2023)

Effectiveness of Janus kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis
by: A. E. Cheberda, et al.
Published: (2024)

Epigenetic targets of Janus kinase inhibitors are linked to genetic risks of rheumatoid arthritis
by: Haruka Tsuchiya, et al.
Published: (2024)

Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
by: Manuel Morgado, et al.
Published: (2017)

Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo
by: Asmaa Gaber Abdou, et al.
Published: (2018)

Management of vitiligo with topical janus tyrosine kinase inhibitor therapy: An evidence-based review
by: Abrahim Abduelmula, BScN, et al.
Published: (2022)